Mechanisms of NK Cell Activation by the KIR2DL4 Receptor

KIR2DL4 受体激活 NK 细胞的机制

基本信息

  • 批准号:
    6860141
  • 负责人:
  • 金额:
    $ 27.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-03-01 至 2009-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): KIR2DL4 (2DL4; CD158d) is structurally and functionally unique among members of the killer cell Ig-like receptor (KIR) family in humans. Studies indicate that 2DL4 is the only KIR for which mRNA is expressed in all NK cell clones analyzed, which strongly indicates that it serves a biologically important function. It is also the only KIR that reportedly binds HLA-G, which is almost exclusively expressed on fetal-derived trophoblasts that infiltrate the maternal decidua in pregnant women. Thus, 2DL4 has been proposed to play an important role during pregnancy, although additional functional roles are clearly possible, particularly in cancer and virus infection. 2DL4 also stands out as the only NK cell activating receptor that reportedly triggers interferon (IFN)gamma production, but not target cell cytotoxicity in resting human NK cells. In contrast, other NK cell activating receptors initiate a functional response program that leads to both IFNgamma production and cytotoxicity. We hypothesize that the distinctive functional attributes of 2DL4 result from physical linkage to a unique transmembrane accessory protein that couples the receptor to signal transduction cascades that differ from those triggered by other activating receptors. Our preliminary data support this hypothesis. We propose to define the molecular basis for the distinctive functional response program activated by 2DL4 and define the elements that differ from those triggered by other NK cell activating receptors that also stimulate cytolytic responses. The results will allow us to define the molecular basis for activating distinct functional response programs in NK cells when they encounter trophoblasts, tumor cells, or virus infected cells. We will pursue the following specific aims to achieve this goal: 1 How do structural elements of KIR2DL4 contribute to its unique functions? 2. What accessory signaling protein is associated with the transmembrane domain of KIR2DL4 to transduce intracellular signals? 3. What are the molecular mechanisms by which KIR2DL4 transduces unique activation signals inhuman NK cells?
描述(由申请人提供):KIR 2DL 4(2DL 4; CD 158 d)在人体杀伤细胞Ig样受体(KIR)家族成员中具有独特的结构和功能。研究表明,2DL 4是唯一的KIR,其mRNA在所分析的所有NK细胞克隆中表达,这强烈表明其具有生物学重要功能。据报道,它也是唯一结合HLA-G的KIR,HLA-G几乎仅在渗入孕妇母体蜕膜的胎儿来源的滋养层上表达。因此,2DL 4已被提出在妊娠期间发挥重要作用,尽管其他功能作用显然是可能的,特别是在癌症和病毒感染中。 2DL 4还作为据报道触发干扰素(IFN)γ产生但不触发静息人NK细胞中的靶细胞细胞毒性的唯一NK细胞活化受体而突出。相比之下,其他NK细胞活化受体启动导致IFN γ产生和细胞毒性的功能性应答程序。我们假设,2DL 4的独特的功能属性的结果从物理连接到一个独特的跨膜辅助蛋白,耦合受体的信号转导级联反应,从其他激活受体所触发的不同。我们的初步数据支持这一假设。我们建议定义由2DL 4激活的独特功能反应程序的分子基础,并定义与其他NK细胞激活受体(也刺激细胞溶解反应)触发的不同的元素。这些结果将使我们能够确定当NK细胞遇到滋养层细胞、肿瘤细胞或病毒感染细胞时激活NK细胞中不同功能反应程序的分子基础。为实现这一目标,我们将努力实现以下具体目标: 1 KIR 2DL 4的结构元件如何有助于其独特的功能? 2.什么辅助信号蛋白与KIR 2DL 4的跨膜结构域相关,以抑制细胞内信号? 3. KIR 2DL 4通过什么分子机制转导人类NK细胞独特的激活信号?

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kerry S Campbell其他文献

Kerry S Campbell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kerry S Campbell', 18)}}的其他基金

Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
  • 批准号:
    10319570
  • 财政年份:
    2020
  • 资助金额:
    $ 27.78万
  • 项目类别:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
  • 批准号:
    10544158
  • 财政年份:
    2020
  • 资助金额:
    $ 27.78万
  • 项目类别:
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
免疫受体簇在控制 NK 细胞抗体依赖性 FcγRIIIa 介导的细胞毒性中的作用
  • 批准号:
    10078249
  • 财政年份:
    2020
  • 资助金额:
    $ 27.78万
  • 项目类别:
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
了解惰性淋巴细胞增殖性疾病的心理社会和免疫反应
  • 批准号:
    9038558
  • 财政年份:
    2016
  • 资助金额:
    $ 27.78万
  • 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
  • 批准号:
    8073248
  • 财政年份:
    2010
  • 资助金额:
    $ 27.78万
  • 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
  • 批准号:
    7860305
  • 财政年份:
    2009
  • 资助金额:
    $ 27.78万
  • 项目类别:
Characterization of Type-2 Cytokine-Producing NK Cells
2 型细胞因子产生 NK 细胞的表征
  • 批准号:
    7707072
  • 财政年份:
    2009
  • 资助金额:
    $ 27.78万
  • 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
  • 批准号:
    7332209
  • 财政年份:
    2004
  • 资助金额:
    $ 27.78万
  • 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
  • 批准号:
    7168804
  • 财政年份:
    2004
  • 资助金额:
    $ 27.78万
  • 项目类别:
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
KIR2DL4 受体激活 NK 细胞的机制
  • 批准号:
    7013613
  • 财政年份:
    2004
  • 资助金额:
    $ 27.78万
  • 项目类别:

相似海外基金

SBIR Phase I: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia via the Antibody Dependent Cell-mediated Cytotoxicity Mechanism of Natural Killer Cells
SBIR 第一期:通过抗体依赖性细胞介导的自然杀伤细胞的细胞毒性机制,针对急性髓性白血病新抗原的抗体疗法
  • 批准号:
    2246487
  • 财政年份:
    2023
  • 资助金额:
    $ 27.78万
  • 项目类别:
    Standard Grant
Identification of resistant mechanisms of tumor cells against CAR-T cell-mediated cytotoxicity
肿瘤细胞对 CAR-T 细胞介导的细胞毒性的耐药机制的鉴定
  • 批准号:
    22H02910
  • 财政年份:
    2022
  • 资助金额:
    $ 27.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New regulators of natural killer cell-mediated cytotoxicity
自然杀伤细胞介导的细胞毒性的新调节剂
  • 批准号:
    10370297
  • 财政年份:
    2021
  • 资助金额:
    $ 27.78万
  • 项目类别:
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells
发现抗体依赖性细胞介导的针对 HIV-1 感染细胞的细胞毒性的新表位
  • 批准号:
    10031027
  • 财政年份:
    2020
  • 资助金额:
    $ 27.78万
  • 项目类别:
Discovery of Novel Epitopes for Antibody Dependent Cell-mediated Cytotoxicity Against HIV-1 Infected Cells
发现抗体依赖性细胞介导的针对 HIV-1 感染细胞的细胞毒性的新表位
  • 批准号:
    10113530
  • 财政年份:
    2020
  • 资助金额:
    $ 27.78万
  • 项目类别:
Unlocking Envelope: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
解锁包膜:通过抗体依赖性细胞介导的细胞毒性实现功能性治愈的新策略
  • 批准号:
    9925499
  • 财政年份:
    2019
  • 资助金额:
    $ 27.78万
  • 项目类别:
Unlocking Envelope: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
解锁包膜:通过抗体依赖性细胞介导的细胞毒性实现功能性治愈的新策略
  • 批准号:
    10176380
  • 财政年份:
    2019
  • 资助金额:
    $ 27.78万
  • 项目类别:
Effects of NK cell adaptation to cytomegalovirus and engagement of TIGIT on HIV-specific antibody-dependent cell-mediated cytotoxicity
NK 细胞对巨细胞病毒的适应和 TIGIT 参与对 HIV 特异性抗体依赖性细胞介导的细胞毒性的影响
  • 批准号:
    400251
  • 财政年份:
    2019
  • 资助金额:
    $ 27.78万
  • 项目类别:
Unlocking Env: A New Strategy for a Functional Cure Through Antibody-Dependent Cell-Mediated Cytotoxicity
解锁 Env:通过抗体依赖性细胞介导的细胞毒性实现功能性治愈的新策略
  • 批准号:
    9273185
  • 财政年份:
    2017
  • 资助金额:
    $ 27.78万
  • 项目类别:
A NOVEL ASSAY FOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY
抗体依赖性细胞介导的细胞毒性的新型检测方法
  • 批准号:
    8357976
  • 财政年份:
    2011
  • 资助金额:
    $ 27.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了